EDITAS MEDICINE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.83 USD | -3.16% |
|
-1.02% | -42.45% |
| 14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
| 09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 495M | - | |||||
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
